( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Heather S. Snyder, Pharm.D., BCPS, Vinaya Rao, M.D., Amy G. Krauss, Pharm.D., BCPS, Alison L. Apple, M.S., D.Ph., Dagny L. Ulrich, Ph.D. and *Benjamin T. Duhart, Jr., M.S., Pharm.D.


Purpose: Optimal dosing of rabbit antithymocyte globulin (rATG) remains undefined and varies between transplant centers. Previously the Methodist University Hospital Transplant Institute (MUHTI) based rATG dosing on kidney graft function (GF) following transplantation, but now utilizes risk stratification (RS) to guide dosing. The study aim was to evaluate outcomes of the RS dosing protocol in kidney transplant recipients as compared to the GF protocol. Methods: A retrospective chart review was done to identify adult patients who underwent single-organ kidney transplantation at the MUHTI and received rATG induction using the GF or RS protocol. The following 1 year outcomes were compared between groups: mean cumulative rATG induction dose, SCr and eGFR, patient and graft survival, episodes of biopsy-proven acute rejection, and infection with BK Polyoma virus and/or cytomegalovirus. Fisher’s exact test was used to analyze categorical variables and student’s t-test was used for continuous variables. A Kaplan-Meier analysis was used to compare patient and graft survival. Results: Of the 100 patients studied, 50 were dosed under the GF protocol and 50 were dosed using the RS protocol. The mean cumulative rATG dose in the GF group was 7.4 ± 2 mg/kg compared to 5.4 ± 1 mg/kg in the RS group (p<0.05). At 1 year renal function was significantly better in the RS group versus the GF group (p<0.05) and patient and graft survival were similar between groups p>0.05). There was a higher incidence of acute rejection in the RS group (14%) versus the GF group (8%); however, this difference was not statistically significant. The incidence of infection with BK Polyoma virus and cytomegalovirus were similar between groups (p>0.05). Conclusion: The RS dosing protocol for rATG improved renal outcomes without compromising patient or graft survival and led to a decrease in the mean cumulative rATG dose in kidney transplant recipients.

Keywords: Rabbit antithymocyte globulin (rATG), risk stratification, kidney transplant this study was presented at the ACCP Annual Meeting, Albuquerque, NM, October 13-16, 2013.

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 June 2021 Issue has been Published, Kindly check it on


    JUNE Issue has been successfully launched on 1 June 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )